Back
Corvus Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$19.03
Seasonality Move:
-12.7%
7 Day Trial
ALL ACCESS PASS
$
7
Corvus Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 39.4% based on the past 9 years of stock performance.
-
Corvus Pharmaceuticals, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Corvus Pharmaceuticals, Inc. Stock Undervalued?The current Corvus Pharmaceuticals, Inc. [CRVS] share price is $19.74. The Score for CRVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 39.4% based on the past 9 years of stock performance.
Corvus Pharmaceuticals, Inc. Stock Rating
Buy
60
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Is Corvus Pharmaceuticals, Inc. overpriced?
-
Corvus Pharmaceuticals, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Corvus Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
26.95
52-Week Low:
2.54
Prediction Charts
Market Cap:
1.5B
Price in USD:
19.74
Volume:
1.7M
Beta:
1.24
Technical Analysis
SMA50:
12.43
SMA100:
9.94
SMA200:
7.15
52-Wk Change:
297.98%
Stock Predictions
-
Is Corvus Pharmaceuticals, Inc. stock public?Yes, Corvus Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Corvus Pharmaceuticals, Inc. stock quote today?The Corvus Pharmaceuticals, Inc. stock price is 19.74 USD today.
-
How to buy Corvus Pharmaceuticals, Inc. stock online?You can buy Corvus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 25.56 | 25.10 | 26.95 | 24.99 |
| Jan-26 | 24.17 | 23.01 | 24.42 | 20.70 |
| Jan-27 | 23.10 | 22.08 | 23.51 | 21.80 |
| Jan-28 | 22.09 | 20.54 | 22.27 | 20.34 |
| Jan-29 | 20.82 | 20.94 | 22.10 | 20.38 |
| Jan-30 | 20.69 | 20.70 | 21.71 | 20.20 |
| Feb-2 | 20.70 | 20.98 | 22.34 | 20.55 |
| Feb-3 | 21.00 | 21.34 | 21.74 | 21.00 |
| Feb-4 | 21.44 | 20.82 | 21.97 | 20.44 |
| Feb-5 | 20.63 | 19.06 | 21.22 | 18.92 |
| Feb-6 | 19.06 | 20.46 | 20.78 | 19.06 |
| Feb-9 | 20.54 | 20.41 | 21.57 | 20.09 |
| Feb-10 | 20.10 | 19.58 | 20.34 | 19.45 |
| Feb-11 | 19.46 | 19.74 | 19.79 | 18.50 |
Corvus Pharmaceuticals, Inc. Earnings
Corvus Pharmaceuticals, Inc. Earnings Report: Per Share Corvus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corvus Pharmaceuticals, Inc. Forecast Revenue Growth
Corvus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.16 per share.
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.